cysteine has been researched along with Respiratory Distress Syndrome, Newborn in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Garbe, W; Griese, M; Hepping, N; Lange, L; Lohse, P | 1 |
| Ballard, PL; Beers, MF; Gonzales, LW; Guttentag, SH; Hamvas, A; Longmore, WJ; Moxley, MA; Nogee, LM; Solarin, KO | 1 |
| Parker, CM; Smith, GG; Sprince, H | 1 |
| Barashnev, IuI; Vel'tishchev, IuE | 1 |
1 review(s) available for cysteine and Respiratory Distress Syndrome, Newborn
| Article | Year |
|---|---|
[Early detection of hereditary anomalies of metabolism in children (screening programs)].
Topics: Age Factors; Cysteine; Galactosemias; Glucosephosphate Dehydrogenase Deficiency; Glutamate Dehydrogenase; Histidine Ammonia-Lyase; Humans; Hyperlipidemias; Infant, Newborn; Leucine; Mass Screening; Metabolism, Inborn Errors; Oxalates; Phenylketonurias; Pyruvate Kinase; Respiratory Distress Syndrome, Newborn; Time Factors; UTP-Hexose-1-Phosphate Uridylyltransferase | 1975 |
3 other study(ies) available for cysteine and Respiratory Distress Syndrome, Newborn
| Article | Year |
|---|---|
Successful treatment of neonatal respiratory failure caused by a novel surfactant protein C p.Cys121Gly mutation with hydroxychloroquine.
Topics: Amino Acid Substitution; Cesarean Section; Cysteine; DNA Mutational Analysis; Exons; Female; Follow-Up Studies; Genetic Carrier Screening; Glycine; Humans; Hydroxychloroquine; Infant; Infant, Newborn; Pulmonary Surfactant-Associated Protein C; Respiratory Distress Syndrome, Newborn; Respiratory Insufficiency | 2013 |
Pulmonary surfactant metabolism in infants lacking surfactant protein B.
Topics: Acetates; Blotting, Western; Cysteine; Fetus; Gene Expression; Genotype; Humans; Infant; Infant, Newborn; Methionine; Phosphatidylcholines; Phosphatidylglycerols; Proteolipids; Pulmonary Surfactant-Associated Proteins; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; RNA, Messenger; Sulfur Radioisotopes; Transcription, Genetic; Tritium | 2000 |
Comparison of protection by L-ascorbic acid, L-cysteine, and adrenergic-blocking agents against acetaldehyde, acrolein, and formaldehyde toxicity: implications in smoking.
Topics: Acetaldehyde; Acrolein; Adrenergic beta-Antagonists; Aldehydes; Anesthesia; Animals; Ascorbic Acid; Cysteine; Formaldehyde; Humans; Infant, Newborn; Male; Pain; Rats; Respiratory Distress Syndrome, Newborn; Smoking; Time Factors | 1979 |